Update on intra-arterial chemotherapy for retinoblastoma.
Publication/Presentation Date
1-1-2014
Abstract
The tools for managing retinoblastoma have been increasing in the past decade. While globe-salvage still relies heavily on intravenous chemotherapy, tumors in advanced stage that failed chemotherapy are now referred for intra-arterial chemotherapy (IAC) to avoid enucleation. However, IAC still has many obstacles to overcome. We present an update on the indications, complications, limitations, success, and technical aspects of IAC. Given its safety and high efficacy, it is expected that IAC will replace conventional strategies and will become a first-line option even for tumors that are amenable for other strategies.
Volume
2014
First Page
869604
Last Page
869604
ISSN
1537-744X
Published In/Presented At
Zanaty, M., Barros, G., Chalouhi, N., Starke, R. M., Manasseh, P., Tjoumakaris, S. I., Shields, C. L., Hasan, D., Bulsara, K., Rosenwasser, R. H., & Jabbour, P. (2014). Update on intra-arterial chemotherapy for retinoblastoma. TheScientificWorldJournal, 2014, 869604. https://doi.org/10.1155/2014/869604
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
25405236
Department(s)
Administration and Leadership
Document Type
Article